(19)
(11) EP 4 093 751 A1

(12)

(43) Date of publication:
30.11.2022 Bulletin 2022/48

(21) Application number: 21706431.0

(22) Date of filing: 22.01.2021
(51) International Patent Classification (IPC): 
C07K 14/435(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/435
(86) International application number:
PCT/US2021/014767
(87) International publication number:
WO 2021/151001 (29.07.2021 Gazette 2021/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 22.01.2020 US 202062964643 P
27.04.2020 US 202063016056 P

(71) Applicant: Outpace Bio, Inc.
Seattle, WA 98109 (US)

(72) Inventors:
  • LAJOIE, Marc
    Seattle, Washington 98125 (US)
  • BOYKEN, Scott
    Seattle, Washington 98109 (US)
  • LANGAN, Robert
    Seattle, Washington 98122 (US)
  • MOFFETT, Howell
    Seattle, Washington 98102 (US)

(74) Representative: Cooley (UK) LLP 
22 Bishopsgate
London EC2N 4BQ
London EC2N 4BQ (GB)

   


(54) CHIMERIC POLYPEPTIDES